Small Donors, Big Impact: Optimizing Organ Utilization in Simultaneous Pancreas and Kidney Transplantation From Extra Small Pediatric Donors

2024-9-1

Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance

2024-9-1

Procurement Trends, Indications, and Outcomes of Heart–Lung Transplantation in the Contemporary Era

2024-9-1

Strategy and Outcomes of Cardiac Surgery in Patients With Cirrhosis: Comprehensive Approach With Liver Transplant Program

2024-9-1

Issue Information

2024-9-1

Seasonal Patterns of Living Kidney Donation in the United States From 1995 to 2019

2024-9-1

Effect of CMV Mismatch on Heart Transplant Outcomes Using a Surveillance and Preemptive Strategy

2024-9-1

Analysis of the waitlist performance and post‐transplant outcomes of lung transplant in elderly recipients in Korea: A nationwide cohort study

2024-9-1

Risk Factors for Sinusoidal Obstruction Syndrome After Hematopoietic Stem Cell Transplantation in Children and Young Adults: A Systematic Review and Meta‐Analysis

2024-9-1

The Cost of Procuring Deceased Donor Livers: Evidence From US Organ Procurement Organization Cost Reports, 2013–2018

2024-9-1

Risk and Reward: Nationwide Analysis of Cardiac Transplant Center Variation in Organ Travel Distance and the Effects on Outcomes

2024-9-1

Sarcopenia in Children Post Liver Transplant: Development of a Home‐Based Video Program to Support Muscle Strength and Function—A Pre–Post Controlled Pilot Study

2024-9-1

Measuring the Impact of Postsimultaneous Pancreas–Kidney Transplantation Complications: Comparing the Comprehensive Complication Index and Clavien–Dindo Classification

2024-8-30

Assessing the Role of Primary Heart Failure Etiology on Cardiac Transplant Outcomes

2024-8-30

Regional Disparities in Kidney Transplant Allocation in Brazil: A Retrospective Cohort Study

2024-8-30

Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung Transplantation

2024-8-29

Determining Predictors of Actual Living Kidney Donation Based on Potential Donor Characteristics

2024-8-27

Risk Factors and Outcomes Associated With the Development of Persistent Acute Kidney Injury in Non‐Renal Solid Organ Transplant Recipients: Systematic Review and Meta‐Analysis

2024-8-27

Association of Frailty With Clinical and Financial Outcomes Following Liver Transplantation

2024-8-27

Review–Long‐Term Care of Kidney Transplant Patients

2024-8-27

Does Severity of Donor Acute Kidney Injury Influence Outcomes Following Kidney Transplantation?

2024-8-1

Increasing Multiorgan Heart Transplantations From Donation After Circulatory Death Donors in the United States

2024-8-1

The Impact of Donor‐Recipient Human Leukocyte Antigen Matching on Bronchiolitis Obliterans‐Free Survival Among Lung Transplant Recipients With Connective Tissue Diseases

2024-8-1

Efficacy and Safety of Perioperative Angiotensin II Versus Phenylephrine as a First‐Line Continuous Infusion Vasopressor in Kidney Transplant Recipients

2024-8-1

Issue Information

2024-8-1

Evolving Trends and Impact of Waitlist Transfusion on Recipient Outcomes Following Heart Transplantation

2024-8-1

Contemporary Immunosuppression Management and 1‐Year Outcomes in Dual Organ Heart Transplantation

2024-8-1

Utility of Quadratus Lumborum Blocks in Patients Who Undergo Liver Transplant: A Single‐Center Retrospective Study

2024-8-1

Obesogenic Medication Use in End‐Stage Kidney Disease and Association With Transplant Listing

2024-8-1

Posttransplant Lymphoproliferative Disease Following Pancreas Transplantation: A 40 Year Single‐Center Experience

2024-8-1

LCP‐Tacrolimus Extended‐Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients

2024-8-1

Impact of Heart Failure Etiology on Waitlist Mortality in Heart Transplant Candidates Supported With Extracorporeal Membrane Oxygenation

2024-8-1

Impact of Warm Ischemia Time on Donation After Circulatory Death Kidney Transplant Outcomes

2024-8-1

Serum β2‐Microglobulin Predicts Time to Recovery of Delayed Graft Function in Kidney Transplant Recipients

2024-8-1

Prospective Cohort Study Examining the Ability of Performance‐Based and Self‐Reported Frailty Measures to Predict 30‐Day Rehospitalizations After Kidney Transplantation

2024-8-1

Tuscany Normothermic Regional Perfusion Mobile Teams for Controlled Donation After Circulatory Death

2024-8-1

Unique Lessons From the Natural Progression of Rejection in Human Uterine Allografts

2024-8-1

Primary Team Versus Local Recovery in Liver Transplantation in the Modern Era: A National Analysis of the United Network for Organ Sharing Database

2024-8-1

Epstein–Barr Virus‐Associated Smooth Muscle Tumor After Kidney Transplantation: A French Multicenter Retrospective Study

2024-8-1

Graft Steatosis and Donor Diabetes Mellitus Additively Impact on Recipient Outcomes After Liver Transplantation—A European Registry Study

2024-8-1

Significant Long‐Term Prevention of High Sensitization After Kidney Allograft Failure by Maintaining Calcineurin Inhibitor‐Based Immunosuppression

2024-7-1

De Novo Urological Malignancies After Renal Transplantation: An Asian 30‐Year Experience

2024-7-1

SARS‐CoV‐2 Vaccination Rates and Uptake of Tixagevimab‐Cilgavimab Among a Cohort of Pediatric Solid Organ Transplant Recipients

2024-7-1

Impact of Age of Heart Transplant Program on Patient Survival and Post‐Transplant Outcomes

2024-7-1

Changes in Numbers of Glomerular Macrophages Between Two Consecutive Biopsies and the Association With Renal Transplant Graft Survival

2024-7-1

Quality of Life in Patients 20–31 Years After Heart Transplantation

2024-7-1

Gonadotropic Axis, Bone Mass, and Sarcopenia Assessment After Autologous Hematopoietic Stem Cell Transplantation for Lymphoma

2024-7-1

Examining the Influence of a General Surgery Resident's Transplant Experience on Their Pursuit of Transplant Surgery Fellowship

2024-7-1